ATROPHY
Clinical trials for ATROPHY explained in plain language.
Never miss a new study
Get alerted when new ATROPHY trials appear
Sign up with your email to follow new studies for ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for muscle strength in SMA patients on standard therapy
Disease control CompletedThis study tested a drug called apitegromab in 188 people aged 2 to 21 with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking nusinersen or risdiplam. The goal was to see if adding apitegromab could improve muscle function more than a placebo. Partic…
Matched conditions: ATROPHY
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Eye image database aims to predict who will lose sight from AMD
Knowledge-focused CompletedThis study collected eye images from 1,000 people with intermediate age-related macular degeneration (AMD) to build a database. The goal was to find imaging markers that can predict if and when the disease will progress to a more advanced stage with vision loss. Researchers will …
Matched conditions: ATROPHY
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated May 15, 2026 11:59 UTC